Hangzhou Coco Healthcare Products Co.,Ltd.
Symbol: 301009.SZ
SHZ
9.21
CNYDzisiejsza cena rynkowa
89.9693
Wskaźnik P/E
0.0000
Wskaźnik PEG
2.50B
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Hangzhou Coco Healthcare Products Co.,Ltd. (301009-SZ) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 863.1 | 689.5 | 884 | |||||||
balance-sheet.row.short-term-investments | 0 | -20.4 | -21.2 | -23.5 | |||||||
balance-sheet.row.net-receivables | 0 | 213 | 274.5 | 188.2 | |||||||
balance-sheet.row.inventory | 0 | 114.8 | 182.4 | 153.9 | |||||||
balance-sheet.row.other-current-assets | 0 | 13.9 | 12.2 | 27.6 | |||||||
balance-sheet.row.total-current-assets | 0 | 1204.7 | 1158.5 | 1253.8 | |||||||
balance-sheet.row.property-plant-equipment-net | 0 | 663.4 | 670.4 | 694.8 | |||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.intangible-assets | 0 | 82.5 | 84.9 | 87 | |||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 82.5 | 84.9 | 87 | |||||||
balance-sheet.row.long-term-investments | 0 | 30.1 | 21.5 | 23.7 | |||||||
balance-sheet.row.tax-assets | 0 | 10.1 | 8.2 | 2.1 | |||||||
balance-sheet.row.other-non-current-assets | 0 | 1.2 | 5.2 | 24.2 | |||||||
balance-sheet.row.total-non-current-assets | 0 | 787.3 | 790.1 | 831.8 | |||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.total-assets | 0 | 1992 | 1948.6 | 2085.6 | |||||||
balance-sheet.row.account-payables | 0 | 439 | 429.9 | 528.5 | |||||||
balance-sheet.row.short-term-debt | 0 | 6.2 | 1.4 | 1.5 | |||||||
balance-sheet.row.tax-payables | 0 | 5.5 | 6.5 | 1.4 | |||||||
balance-sheet.row.long-term-debt-total | 0 | 11.9 | 3.3 | 5.1 | |||||||
Deferred Revenue Non Current | 0 | 45.2 | 39.1 | 6.8 | |||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||
balance-sheet.row.other-current-liab | 0 | 0.6 | 0.8 | 0.6 | |||||||
balance-sheet.row.total-non-current-liabilities | 0 | 57.1 | 42.3 | 11.9 | |||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.capital-lease-obligations | 0 | 11.9 | 3.3 | 5.1 | |||||||
balance-sheet.row.total-liab | 0 | 542.4 | 516.9 | 578.6 | |||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||
balance-sheet.row.common-stock | 0 | 271.9 | 271.9 | 271.9 | |||||||
balance-sheet.row.retained-earnings | 0 | 300.4 | 284.3 | 348.8 | |||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 73.2 | 70.8 | |||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 800.4 | 723.2 | 723.2 | |||||||
balance-sheet.row.total-stockholders-equity | 0 | 1372.7 | 1352.6 | 1414.7 | |||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1992 | 1948.6 | 2085.6 | |||||||
balance-sheet.row.minority-interest | 0 | 76.9 | 79.2 | 92.3 | |||||||
balance-sheet.row.total-equity | 0 | 1449.6 | 1431.8 | 1507 | |||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||
Total Investments | 0 | 9.7 | 0.3 | 0.3 | |||||||
balance-sheet.row.total-debt | 0 | 18.1 | 4.6 | 6.6 | |||||||
balance-sheet.row.net-debt | 0 | -845 | -684.8 | -877.4 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -56.2 | 39.4 | 223.1 | ||||||
cash-flows.row.depreciation-and-amortization | 0 | 61.3 | 49.4 | 39.2 | ||||||
cash-flows.row.deferred-income-tax | 0 | -6.1 | 3.8 | -3.6 | ||||||
cash-flows.row.stock-based-compensation | 0 | 6.1 | -3.8 | 3.6 | ||||||
cash-flows.row.change-in-working-capital | 0 | -110.7 | -53.8 | 67.3 | ||||||
cash-flows.row.account-receivables | 0 | -31 | 114.1 | -101.2 | ||||||
cash-flows.row.inventory | 0 | -40.2 | -34 | 4.5 | ||||||
cash-flows.row.account-payables | 0 | -33.5 | -137.7 | 167.6 | ||||||
cash-flows.row.other-working-capital | 0 | -6.1 | 3.8 | -3.6 | ||||||
cash-flows.row.other-non-cash-items | 0 | 68.5 | 15.4 | 66.2 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -116.4 | -240.4 | -220.7 | ||||||
cash-flows.row.acquisitions-net | 0 | 0.6 | 25 | 0.1 | ||||||
cash-flows.row.purchases-of-investments | 0 | -65 | -95 | -150.3 | ||||||
cash-flows.row.sales-maturities-of-investments | 0 | 65.2 | 220.1 | 51.1 | ||||||
cash-flows.row.other-investing-activites | 0 | 3.4 | -24.5 | 8.3 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -112.1 | -114.9 | -311.5 | ||||||
cash-flows.row.debt-repayment | 0 | 0 | -149.1 | -80.6 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.dividends-paid | 0 | -19 | -0.9 | -23.6 | ||||||
cash-flows.row.other-financing-activites | 0 | -30.8 | 833.8 | 132.7 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -49.9 | 683.8 | 28.5 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 4.2 | -2.6 | -11.6 | ||||||
cash-flows.row.net-change-in-cash | 0 | -195 | 616.8 | 101.2 | ||||||
cash-flows.row.cash-at-end-of-period | 0 | 639.5 | 834.4 | 217.6 | ||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 834.4 | 217.6 | 116.4 | ||||||
cash-flows.row.operating-cash-flow | 0 | -37.2 | 50.5 | 395.9 | ||||||
cash-flows.row.capital-expenditure | 0 | -116.4 | -240.4 | -220.7 | ||||||
cash-flows.row.free-cash-flow | 0 | -153.6 | -189.9 | 175.1 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1081.5 | 1186.3 | 1186.4 | |||||||
income-statement-row.row.cost-of-revenue | 0 | 890.6 | 1030.9 | 965.3 | |||||||
income-statement-row.row.gross-profit | 0 | 190.9 | 155.4 | 221.1 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.other-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.operating-expenses | 0 | 175.2 | 171.3 | 176.8 | |||||||
income-statement-row.row.cost-and-expenses | 0 | 1065.7 | 1202.2 | 1142.1 | |||||||
income-statement-row.row.interest-income | 0 | 24.2 | 23.3 | 12.6 | |||||||
income-statement-row.row.interest-expense | 0 | 0.7 | 0.3 | 1 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.total-operating-expenses | 0 | -0.8 | -0.9 | -1.8 | |||||||
income-statement-row.row.interest-expense | 0 | 0.7 | 0.3 | 1 | |||||||
income-statement-row.row.depreciation-and-amortization | 0 | 56.8 | 61.3 | 49.4 | |||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||
income-statement-row.row.operating-income | 0 | 20.2 | -55.5 | 45.3 | |||||||
income-statement-row.row.income-before-tax | 0 | 19.5 | -56.4 | 43.5 | |||||||
income-statement-row.row.income-tax-expense | 0 | 1.7 | -0.1 | 4.1 | |||||||
income-statement-row.row.net-income | 0 | 20.2 | -43.1 | 39.7 |
Często zadawane pytania
Ile wynosi Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) aktywów ogółem?
Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) całkowite aktywa to 1992017074.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.187.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 0.539.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.026.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.028.
Co to jest Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 20184911.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 18052009.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 175169142.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.